Reagents
Aptiva®
Aptiva’s particle-based multi-analyte technology (PMAT) simultaneously detects multiple autoantibodies, increasing clinical confidence and diagnostic precision. Realize the full potential of multi-analyte testing with clinically significant biomarkers that demonstrate excellent clinical performance.
Increase diagnostic power with antibody profiling.
Aptiva delivers a more complete diagnostic profile to support clinical decision-making. Robust antibody profiles have higher diagnostic confidence than individual antibodies, and the probability of disease increases with multiple positive antibodies.
Bizzaro N, et al. Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases. Arthritis Res & Ther. 2022;24:278
Reagents
*Only available outside of the US
**For Sale in the USA ONLY
*Only available outside of the US
**For Sale in the USA ONLY